Compile Data Set for Download or QSAR
Report error Found 123 of Enz. Inhib. data with enzyme = 'Cathepsin S' and Substrate = 'BDBM225228'
TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225123(US9328118, 24)
Affinity DataIC50: 0.760nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225213(US9328118, 145)
Affinity DataIC50: 1nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225205(US9328118, 137)
Affinity DataIC50: 1nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225138(US9328118, 39)
Affinity DataIC50: 1nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225125(US9328118, 26)
Affinity DataIC50: 1.20nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225168(US9328118, 84)
Affinity DataIC50: 1.30nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225163(US9328118, 79)
Affinity DataIC50: 1.40nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225127(US9328118, 28)
Affinity DataIC50: 1.40nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225210(US9328118, 142)
Affinity DataIC50: 1.5nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225211(US9328118, 143)
Affinity DataIC50: 1.5nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225222(US9328118, 155)
Affinity DataIC50: 1.5nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225204(US9328118, 136)
Affinity DataIC50: 1.5nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225111(US9328118, 8)
Affinity DataIC50: 1.60nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225220(US9328118, 153)
Affinity DataIC50: 1.60nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225124(US9328118, 25)
Affinity DataIC50: 1.60nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225156(US9328118, 72)
Affinity DataIC50: 1.60nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225119(US9328118, 19)
Affinity DataIC50: 1.70nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225133(US9328118, 34)
Affinity DataIC50: 1.70nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225202(US9328118, 122)
Affinity DataIC50: 1.70nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225218(US9328118, 150)
Affinity DataIC50: 1.70nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225113(US9328118, 11)
Affinity DataIC50: 1.90nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225193(US9328118, 113)
Affinity DataIC50: 1.90nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225126(US9328118, 27)
Affinity DataIC50: 1.90nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225121(US9328118, 21)
Affinity DataIC50: 1.90nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225122(US9328118, 23)
Affinity DataIC50: 1.90nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225169(US9328118, 86)
Affinity DataIC50: 1.90nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225182(US9328118, 102)
Affinity DataIC50: 2nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225209(US9328118, 141)
Affinity DataIC50: 2nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225175(US9328118, 92)
Affinity DataIC50: 2nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225157(US9328118, 73)
Affinity DataIC50: 2nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225155(US9328118, 71)
Affinity DataIC50: 2nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225134(US9328118, 35)
Affinity DataIC50: 2.10nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225176(US9328118, 93)
Affinity DataIC50: 2.10nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225208(US9328118, 140)
Affinity DataIC50: 2.10nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225224(US9328118, 157)
Affinity DataIC50: 2.10nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225174(US9328118, 91)
Affinity DataIC50: 2.10nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225144(US9328118, 47)
Affinity DataIC50: 2.10nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225207(US9328118, 139)
Affinity DataIC50: 2.10nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225203(US9328118, 135)
Affinity DataIC50: 2.10nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225200(US9328118, 120)
Affinity DataIC50: 2.10nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225158(US9328118, 74)
Affinity DataIC50: 2.20nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225219(US9328118, 152)
Affinity DataIC50: 2.20nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225153(US9328118, 68)
Affinity DataIC50: 2.20nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225154(US9328118, 70)
Affinity DataIC50: 2.20nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225185(US9328118, 105)
Affinity DataIC50: 2.20nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225198(US9328118, 118)
Affinity DataIC50: 2.30nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225197(US9328118, 117)
Affinity DataIC50: 2.30nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225131(US9328118, 32)
Affinity DataIC50: 2.30nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225178(US9328118, 95)
Affinity DataIC50: 2.30nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225116(US9328118, 14)
Affinity DataIC50: 2.30nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
US Patent

Displayed 1 to 50 (of 123 total ) | Next | Last >>
Jump to: